These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21495957)
1. Neurotrophic factor treatment of neurological disorders: the benefits of a pleiotropic treatment approach. Commentary. Muresanu DF; Doppler E; Novak P CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):415-6. PubMed ID: 21495957 [No Abstract] [Full Text] [Related]
2. [4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"]. Gomazkov OA Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):69-70. PubMed ID: 12378888 [No Abstract] [Full Text] [Related]
3. Cerebrolysin and its emerging clinical applications in psychiatry. Kapoor S Aust N Z J Psychiatry; 2013 Jul; 47(7):685. PubMed ID: 23405015 [No Abstract] [Full Text] [Related]
4. Safety profile of Cerebrolysin: clinical experience from dementia and stroke trials. Thome J; Doppler E Drugs Today (Barc); 2012 Apr; 48 Suppl A():63-9. PubMed ID: 22514795 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]. Gusev EI; Skvortsova VI; Miasoedov NF; Nezavibat'ko VN; Zhuravleva EIu; Vanichkin AV Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):26-34. PubMed ID: 11517472 [TBL] [Abstract][Full Text] [Related]
6. [Does treatment with piracetam in stroke patients with aphasia make sense?]. Schmidtke K Dtsch Med Wochenschr; 2002 Dec; 127(49):2636. PubMed ID: 12469280 [No Abstract] [Full Text] [Related]
7. Harbinger of hope or commodity fetishism: "re-cognizing" dementia in an age of therapeutic agents. Graham JE Int Psychogeriatr; 2001 Jun; 13(2):131-4. PubMed ID: 11495389 [No Abstract] [Full Text] [Related]
8. Changes at the focus of experimental ischemic stroke treated with neuroprotective agents. Onishchenko LS; Gaikova ON; Yanishevskii SN Neurosci Behav Physiol; 2008 Jan; 38(1):49-54. PubMed ID: 18097760 [TBL] [Abstract][Full Text] [Related]
9. Do we have drugs for dementia? No. Pryse-Phillips W Arch Neurol; 1999 Jun; 56(6):735-7. PubMed ID: 10369315 [No Abstract] [Full Text] [Related]
10. What's new with neuroprotective agents in stroke? Bankhead C Drugs R D; 1999 Jan; 1(1):49-51. PubMed ID: 10565987 [No Abstract] [Full Text] [Related]
11. [Cerebrolysin for acute ischemic stroke]. iganshina LE; Abakumova TR Vestn Ross Akad Med Nauk; 2013; (1):21-9. PubMed ID: 23805635 [TBL] [Abstract][Full Text] [Related]
12. [Need for studies aimed at the prevention of oncologic diseases]. Volegov AI Vestn Ross Akad Med Nauk; 2001; (6):52-4. PubMed ID: 11517878 [No Abstract] [Full Text] [Related]
16. Accelerated recovery from acute brain injuries: clinical efficacy of neurotrophic treatment in stroke and traumatic brain injuries. Bornstein N; Poon WS Drugs Today (Barc); 2012 Apr; 48 Suppl A():43-61. PubMed ID: 22514794 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacological approaches to the therapy of Alzheimer's disease]. Gavrilova SI Vestn Ross Akad Med Nauk; 2006; (9-10):30-4. PubMed ID: 17111921 [TBL] [Abstract][Full Text] [Related]
18. Hope Dies Last-Evidence Again Fails to Support a Neuroprotectant: Cerebrolysin for Acute Ischemic Stroke. Bereczki D Stroke; 2017 Sep; 48(9):2343-2344. PubMed ID: 28747461 [No Abstract] [Full Text] [Related]
19. [Therapy approaches in cerebral cognitive deficits--neuropsychiatric aspects]. Reisecker F Wien Med Wochenschr; 1996; 146(21-22):546-8. PubMed ID: 9092214 [TBL] [Abstract][Full Text] [Related]
20. An overview of acute stroke therapy: past, present, and future. Fisher M; Schaebitz W Arch Intern Med; 2000 Nov; 160(21):3196-206. PubMed ID: 11088079 [No Abstract] [Full Text] [Related] [Next] [New Search]